The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
Official Title: Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology; Non-interventional, Observational, Prospective Study
Study ID: NCT01626547
Brief Summary: The purpose of this study is to observe correction of haemoglobin (Hb) levels in patients receiving chemotherapy as a consequence of a solid tumour, a malignant lymphoma or a multiple myeloma and who are treated with Retacrit™.
Detailed Description: This is a non-interventional, descriptive, national, multi-site, longitudinal and prospective observational study in adult patients who are suffering from cancer or malignant blood disease and whose chemotherapy treatment has induced symptomatic anaemia and being treated with Retacrit® to correct haemoglobin levels.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Alzey, , Germany
, Bad Säckigen, , Germany
, Berlin, , Germany
, Berlin, , Germany
, Berlin, , Germany
, Bonn, , Germany
, Bonn, , Germany
, Borken, , Germany
, Brandenburg, , Germany
, Chemnitz, , Germany
, Cottbus, , Germany
, Essen, , Germany
, Frankenthal, , Germany
, Garbsen, , Germany
, Halberstadt, , Germany
, Hannover, , Germany
, Herne, , Germany
, Holzkirchen, , Germany
, Krefeld, , Germany
, München, , Germany
, München, , Germany
, Münster, , Germany
, Neuss, , Germany
, Nürnberg, , Germany
, Oberhausen, , Germany
, Oberhausen, , Germany
, Olpe, , Germany
, Oranienburg, , Germany
, Paderborn, , Germany
, Parchim, , Germany
, Plauen, , Germany
, Remscheid, , Germany
, Rodgau, , Germany
, Rötha, , Germany
, Schönebeck, , Germany
, Soest, , Germany
, Stralsund, , Germany
, Stuttgart, , Germany
, Velbert, , Germany